ARKK vs FATE
ARK Innovation ETF (ARKK) versus Fate Therapeutics Inc (FATE) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
ARKK currently screens at market cap $0. FATE currently screens at market cap $331.0M.
Not investment advice. Open the ARKK and FATE stock pages for the full models.
Not investment advice.